Literature DB >> 9094619

Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.

P M Cannon1, S Matthews, N Clark, E D Byles, O Iourin, D J Hockley, S M Kingsman, A J Kingsman.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) matrix protein, p17, plays important roles in both the early and late stages of the viral life cycle. Using our previously determined solution structure of p17, we have undertaken a rational mutagenesis program aimed at mapping structure-function relationships within the molecule. Amino acids hypothesized to be important for p17 function were mutated and examined for effect in an infectious proviral clone of HIV-1. In parallel, we analyzed by nuclear magnetic resonance spectroscopy the structure of recombinant p17 protein containing such substitutions. These analyses identified three classes of mutants that were defective in viral replication: (i) proteins containing substitutions at internal residues that grossly distorted the structure of recombinant p17 and prevented viral particle formation, (ii) mutations at putative p17 trimer interfaces that allowed correct folding of recombinant protein but produced virus that was defective in particle assembly, and (iii) substitution of basic residues in helix A that caused some relocation of virus assembly to intracellular locations and produced normally budded virions that were completely noninfectious.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094619      PMCID: PMC191494          DOI: 10.1128/JVI.71.5.3474-3483.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.

Authors:  X Yu; X Yuan; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.

Authors:  S A González; J L Affranchino; H R Gelderblom; A Burny
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

6.  Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.

Authors:  C T Wang; E Barklis
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.

Authors:  P Gallay; S Swingler; C Aiken; D Trono
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

8.  The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle.

Authors:  X Yu; Q C Yu; T H Lee; M Essex
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.

Authors:  H R Gelderblom; E H Hausmann; M Ozel; G Pauli; M A Koch
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

10.  Human immunodeficiency virus infection of cells arrested in the cell cycle.

Authors:  P Lewis; M Hensel; M Emerman
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  35 in total

1.  Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.

Authors:  R E Kiernan; A Ono; E O Freed
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.

Authors:  Zhibin Wu; Jerry Alexandratos; Bryan Ericksen; Jacek Lubkowski; Robert C Gallo; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

3.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

5.  Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.

Authors:  Y Morikawa; W H Zhang; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.

Authors:  Maria A De Francesco; Manuela Baronio; Claudio Poiesi
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

7.  Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Kazuaki Monde; Vineela Chukkapalli; Akira Ono
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

8.  Efficient HIV-1 replication can occur in the absence of the viral matrix protein.

Authors:  H Reil; A A Bukovsky; H R Gelderblom; H G Göttlinger
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

9.  Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells.

Authors:  G Nicholas Llewellyn; Ian B Hogue; Jonathan R Grover; Akira Ono
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

Review 10.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.